Delivery Order SPE2DX22D0019-SPE2D826FCD21
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $22,324.37 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The contract was performed at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation and will be performed at the vendor's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with ultimate completion by August 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger indefinite delivery vehicle, this award reflects AmerisourceBergen's role...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $36,140.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with completion scheduled for November 12, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $35,100.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,441.95 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,917.58 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is performed at the contractor's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $39,775.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order, contract number 4570100029, was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCD21Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $33,368.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 2, 2026, with an ultimate completion date of January 5, 2026. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in comprehensive medical supply procurement for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, including diabetes treatments, neurological medications, pain management pharmaceuticals, and antibiotics. This delivery order falls under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) valued at $999,999,999.00 and extending through December 2026, which serves as a global pharmaceutical support vehicle enabling the company to supply medical commodities to support military healthcare programs worldwide. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's continued selection for these awards reflects the company's demonstrated capability to meet federal procurement requirements through competitive evaluation and its ability to efficiently manage both small-value transactions and substantial orders within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.4k | 1/1/26 |